Network origin in Charles Askew first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Nabgen, Inc.
1
| Private Company | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Charles Askew via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
GeneVentiv Therapeutics, Inc.
 GeneVentiv Therapeutics, Inc. BiotechnologyHealth Technology GeneVentiv Therapeutics, Inc. is a company that is developing the first gene therapy for patients with hemophilia A or B, with or without inhibitors. The company is based in Raleigh, NC. The company's product, Genv-Hem, produces clotting factor Va, which allows for normal clotting in response to injury. Currently, there are no curative gene therapies available for patients with inhibitors. GeneVentiv Therapeutics was founded by Chengwen Li and the CEO is Damon R Race. | Biotechnology | Founder |
Statistics
International
| United States | 2 |
Sectoral
| Health Technology | 2 |
Operational
| Founder | 1 |
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
Most connected contacts
| Insiders | |
|---|---|
| Chengwen Li | 2 |
- Stock Market
- Insiders
- Charles Askew
- Company connections
